August 08, 2013 09:40 ET

SOHM Launches a Unique Protein Supplement First Time in India

I-Prolec™: Maximum Protein, Maximum Uptake

BUENA PARK, CA--(Marketwired - Aug 8, 2013) -  SOHM, Inc. (PINKSHEETS: SHMN), a Generic Pharmaceutical, Neutraceutical and Cosmeceutical manufacturer launched a unique protein supplement I-Prolec™ in India. This unique product is introduced to the Indian market for the first time. This is the part of long list of innovative product pipeline that Sohm would introduce step by step in near future.

Shailesh Shah, President and CEO of SOHM, Inc. stated, "This unique product, I-Prolec™, is formulated keeping in mind all the age groups and genders." Mr. Shah further stated that "I-Prolec™ will help people who have protein deficiency as well as athlete and sports persons who have need of extra proteins, especially for vegetarian diet."

Mr. Shah also stated that this special formulation of I-Prolec™ comes in with ready to absorb Vitamin B6 and Vitamin B9, with ready to absorb Iron (In the form of L Methyl Folate), plus all the minerals and vitamins that would make healthy living a reality. The fact that a single serving dosage is good enough for confirmed patient compliance made I-Prolec™ an instant hit amongst the leading Gynecologists and Pediatricians. SOHM team believes that I-Prolec™ is not only a winning formula developed locally, but is also the most prolific protein supplement that SOHM will launch in USA and other important Global Market in the coming months. Mr. Shah further added that I-Prolec™ has opened up a new stream of revenue for SOHM. I-Prolec™ and products that are in the pipeline in this category would further consolidate the ever growing revenue generation in the coming months.


SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Besides Generic Drugs, SOHM also has manufacturing facilities for Food Supplements and Cosmetics. The Company's global headquarters is located in California, USA, with manufacturing facilities in India. SOHM, Inc. exports generic pharmaceuticals globally, with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia.


This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact Information

  • For More Information Contact
    SOHM Inc.
    Investor Relations